Molecular Imaging Market Size, Share, Trends, Estimated Revenue, Demand And Restraints, New Opportunities And Forecast To 2026
The discipline of medical imaging known as molecular imaging focuses on visualising molecules of medical importancewithin living patients. This is in contrast to histology, which is a common approach for extracting molecular information from preserved tissue samples.
There are some limits to all molecular imaging modalities, which may restrict the expansion of the Molecular Imaging Market. Optical imaging, for example, lacks penetrating depth, particularly when operating at visible wavelengths. The absorption and scattering of light are used to determine molecular structure using depth of penetration. Furthermore, neither optical imaging nor ultrasound can provide whole-body imaging. Although MRI allows for infinite depth penetration and whole-body imaging, it is more expensive than other imaging modalities. Because of the dangerous radiation that PET-CT imaging emits, it is not advised for all patients. It is not suited for pregnant women, for example, since the radiation may damage the foetus.
Medical imaging is used to diagnose and treat certain disorders early on. For solid tumours, for example, new molecular imaging modalities like ultrasound, PET-CT, and MRI can help with earlier and more precise diagnosis and staging, both of which are necessary for effective surgical therapy. In the assessment of dementia, molecular imaging is very significant. Researchers are looking at using new neuroimaging probes, such as FDDNP and amyloid markers, to show aberrant plaques and tangles associated with Alzheimer's disease, according to the Society of Nuclear Medicine and Molecular Imaging.
Read more @ https://cmiaspireblog.blogspot.com/2021/12/molecular-imaging-market-size-share.html